A carregar...

Discovery of first-in-class nanomolar inhibitors of heptosyltransferase I reveals a new aminoglycoside target and potential alternative mechanism of action

Abstract A clinically relevant inhibitor for Heptosyltransferase I (HepI) has been sought after for many years because of its critical role in the biosynthesis of lipopolysaccharides on bacterial cell surfaces. While many labs have discovered or designed novel small molecule inhibitors, these compou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jozafina Milicaj, Bakar A. Hassan, Joy M. Cote, Carlos A. Ramirez-Mondragon, Nadiya Jaunbocus, Angelika Rafalowski, Kaelan R. Patel, Colleen D. Castro, Ramaiah Muthyala, Yuk Y. Sham, Erika A. Taylor
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Portfolio 2022-05-01
Colecção:Scientific Reports
Acesso em linha:https://doi.org/10.1038/s41598-022-10776-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!